ATE197458T1 - Verbesserte antiandrogene - Google Patents

Verbesserte antiandrogene

Info

Publication number
ATE197458T1
ATE197458T1 AT93909730T AT93909730T ATE197458T1 AT E197458 T1 ATE197458 T1 AT E197458T1 AT 93909730 T AT93909730 T AT 93909730T AT 93909730 T AT93909730 T AT 93909730T AT E197458 T1 ATE197458 T1 AT E197458T1
Authority
AT
Austria
Prior art keywords
antiandrogens
androgen
improved
treatment
dependent diseases
Prior art date
Application number
AT93909730T
Other languages
German (de)
English (en)
Inventor
Fernand Labrie
Yves Merand
Shankar M Singh
Original Assignee
Endorech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorech Inc filed Critical Endorech Inc
Application granted granted Critical
Publication of ATE197458T1 publication Critical patent/ATE197458T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0044—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT93909730T 1993-05-17 1993-05-20 Verbesserte antiandrogene ATE197458T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6061293A 1993-05-17 1993-05-17
PCT/CA1993/000216 WO1994026767A1 (en) 1993-05-17 1993-05-20 Improved antiandrogens

Publications (1)

Publication Number Publication Date
ATE197458T1 true ATE197458T1 (de) 2000-11-11

Family

ID=22030624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93909730T ATE197458T1 (de) 1993-05-17 1993-05-20 Verbesserte antiandrogene

Country Status (14)

Country Link
EP (1) EP0650495B1 (enExample)
JP (1) JP2741286B2 (enExample)
KR (1) KR100241228B1 (enExample)
AT (1) ATE197458T1 (enExample)
CA (1) CA2136303A1 (enExample)
CZ (2) CZ285893B6 (enExample)
DE (1) DE69329649D1 (enExample)
FI (1) FI945458L (enExample)
HU (1) HUT69408A (enExample)
PL (1) PL307333A1 (enExample)
RU (1) RU2141966C1 (enExample)
SK (1) SK139194A3 (enExample)
TW (1) TW259791B (enExample)
WO (1) WO1994026767A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
TR200002784T2 (tr) 1998-03-11 2000-12-21 Endorecherche, Inc Tip 5 ve tip 3 17beta-Hidroksisteroid dehidrojenaz inhibitörleri ve bunların kullanımı için metodlar
AU2002259147A1 (en) 2001-05-08 2002-11-18 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases
TWI329108B (en) 2001-09-06 2010-08-21 Schering Corp 17-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
AR036812A1 (es) 2001-10-17 2004-10-06 Schering Corp Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de medicamentos para el tratamiento de enfermedades androgeno-dependientes
JP4563032B2 (ja) * 2002-01-15 2010-10-13 メルク・シャープ・エンド・ドーム・コーポレイション アンドロゲン受容体モジュレータとしての１７−ヒドロキシ−４−アザ−アンドロスタン−３−オン
CL2003002356A1 (es) 2002-11-18 2005-02-11 Schering Corp Compuestos derivados de 1-(1-acetil-piperidin-4-il)-(ester o amida)-4-(bencidrilo sustituido)-2-tert-butil-piperazina, composicion farmaceutica, y su uso en la inhibicion de 17b-hidroxiesteroide deshidrogenasa de tipo 3 y de enfermedades que dependen
JP4585320B2 (ja) 2002-12-17 2010-11-24 シェーリング コーポレイション 男性ホルモン依存性疾患の処置のための１７β−ヒドロキシステロイドデヒドロゲナーゼ３型インヒビター
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1081494A (en) * 1965-09-14 1967-08-31 British Drug Houses Ltd 17ª‡-(alka-1',3'-diynyl)-steroids
US3875188A (en) * 1968-04-10 1975-04-01 Eugene E Galantay 17-Beta-alpha-lower alkyl allene-substituted steroids
JPS5513273A (en) * 1978-07-13 1980-01-30 Kanebo Ltd Readily absorbable thiazolidine prodrug of anti- inflammatory corticosteroid and its drug composition
FR2430952A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives acetyleniques de l'androst 4-ene, leur procede de preparation et leur application comme medicament
AU5856090A (en) * 1989-07-07 1991-02-06 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity

Also Published As

Publication number Publication date
JP2741286B2 (ja) 1998-04-15
FI945458A0 (fi) 1994-11-21
JPH08510988A (ja) 1996-11-19
RU2141966C1 (ru) 1999-11-27
TW259791B (enExample) 1995-10-11
CZ285893B6 (cs) 1999-11-17
SK139194A3 (en) 1995-07-11
FI945458A7 (fi) 1995-01-16
WO1994026767A1 (en) 1994-11-24
CZ282494A3 (en) 1995-12-13
CA2136303A1 (en) 1994-11-24
EP0650495B1 (en) 2000-11-08
HUT69408A (en) 1995-09-28
RU94046463A (ru) 1997-02-27
EP0650495A1 (en) 1995-05-03
FI945458L (fi) 1995-01-16
CZ287991B6 (cs) 2001-03-14
PL307333A1 (en) 1995-05-15
DE69329649D1 (de) 2000-12-14
KR100241228B1 (ko) 2000-02-01

Similar Documents

Publication Publication Date Title
SE9604786D0 (sv) New compounds
BG102600A (en) Carbamoyloxy derivatives of mutilin and their use as bactericides
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
DE69712900D1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
DK0765320T3 (da) Benzimidazolonderivater med central dopaminerg aktivitet
NO305973B1 (no) Anvendelse av quinolin og quinazolinderivater, forbindelsene som sådanne samt antiinflammatoriske midler inneholdende forbindelsene
DE3585980D1 (de) Hydrazinderivate und ihre verwendung.
DE69329649D1 (de) Verbesserte antiandrogene
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
EP0784973A3 (en) Quinoxaline derivatives for treating tinnitus
TW337521B (en) Non-ulcerogenic analgesic/anti-inflammatory cloixin derivative
KR970702869A (ko) 항종양성 인돌로피롤로카르바졸 유도체(antitumor indolopyprolocarbazole derivative)
ATE54912T1 (de) Mevalonolactonaehnliche imidazole und derivate.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties